Richard McFarland

Chief Regulatory Officer at Advanced Regenerative Manufacturing Institute (ARMI)

Speaker

Richard McFarland is the Chief Regulatory Officer at the Advanced Regenerative Manufacturing Institute (ARMI) where he oversees regulatory affairs for ARMI and its BioFabUSA program. Dr. McFarland is also a Principal Consultant at BioFabConsulting. Prior to joining ARMI in 2017, Dr. McFarland was Associate Director for Policy of the Office of Tissues and Advanced Therapies (and its predecessor office) at the Food and Drug Administration’s Center for Biologics Evaluation and Research(FDA/CBER) for eleven years after six years a reviewer in FDA/CBER. In addition he, served on the federal government’s interagency for tissue engineering and regenerative medicine, the Multi-agency Tissue Engineering Sciences group (MATES) for fifteen years, including five years as its Chair. Dr. McFarland received his undergraduate, graduate, and medical school training at the University of North Carolina-Chapel and his post-graduate medical specialty training in anatomic/clinical pathology at University of Texas Southwestern Medical Center in Dallas